Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is injected once a week, every seven days, on the same day each week. That single weekly schedule applies from the very first dose right through to the highest maintenance strength. If you've been wondering whether it's daily, monthly, or something else entirely, the short answer is straightforwardly once weekly — and the rest of this page explains what that actually looks like day to day. Mounjaro is a prescription-only medicine; a prescriber confirms your starting dose and manages your titration schedule after a clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people arrive at their first consultation half-convinced that injectable weight-loss treatment means daily jabs. It doesn't. Mounjaro's once-weekly frequency comes directly from how tirzepatide behaves in the body: its half-life is long enough that a single injection sustains meaningful receptor activity for the full seven days. Injecting more frequently would not improve results and would increase the chance of side effects; less frequently would leave gaps in coverage. Once a week is the pharmacologically correct interval, not a convenience compromise.
The Mounjaro injection uses a pre-filled KwikPen. There is no vial to draw up, no separate syringe to load. You press the pen against the injection site, press the button, and the dose is delivered. Most people pick a day that suits their routine and stick to it, Sunday evening, Monday morning, whatever makes it easy to remember.
The NHS's tirzepatide information confirms the once-weekly schedule and notes that you can take the injection at any time of day, with or without food. That flexibility is one thing daily-injection users often envy.
Life intervenes. The seven-day interval is the target, but the Patient Information Leaflet allows some flexibility: if you miss your usual day, you can inject within a defined window after the missed dose, refer to the leaflet or speak to your prescriber for the exact terms rather than relying on any general summary. What the leaflet is clear about is that you should not take two doses to make up for a missed one.
If you're mid-treatment and wondering how often to inject Mounjaro when your schedule slips, the safest move is always to contact your prescribing team. Our prescribers are available seven days a week specifically for questions like this.
Rotation of injection sites matters as much as timing. The abdomen, outer thigh, and upper arm are all suitable; rotating between them (and within each site) reduces the chance of local reactions such as redness or firmness under the skin. Never inject into the same spot twice running.
This is worth understanding clearly, because it catches people out. The 2.5 mg starting dose is not therapeutic in the way the higher doses are. Its job is settling your system: giving your gut time to adapt to the medicine before the effective doses begin. Most people experience the most noticeable nausea at dose increases rather than between them, which is exactly why the prescriber-led titration exists.
Moves up the dose ladder happen no faster than every four weeks. A prescriber reviews whether you're tolerating the current dose before any increase is made, at nume, that review happens before every repeat supply. If you want a full breakdown of how often you take Mounjaro injections across each stage of the titration schedule, our dedicated guide walks through what to expect at every dose level. The frequency of Mounjaro injections for weight loss remains once weekly throughout; what changes over time is the strength delivered with each injection, not the injection interval itself.
Feeling impatient about slow progress on a lower dose is genuinely common, a question our prescribers hear most weeks. The answer is usually the same: the schedule exists to keep side effects manageable, and rushing it tends to make people stop treatment altogether, which helps nobody.
Mounjaro pens are stored in the fridge (2–8°C) until you're ready to use them. There is a limited window during which the pen can be kept at room temperature, the exact duration is specified in the Patient Information Leaflet, and you should follow that rather than any figure quoted online. Inject at room temperature where possible; a cold pen can feel uncomfortable.
Used needles and pens are clinical waste. A sharps disposal container keeps used pens and needles safe until you can return them to a pharmacy. Never put them in household recycling or general waste.
If you're thinking about the cost side of treatment (how much a month's supply typically runs) our Mounjaro cost guide sets out what's included in a private prescription price and what market prices have looked like since Eli Lilly's September 2025 list-price change. One pen covers four weekly injections, so if you're unsure how often Mounjaro is injected and what that means for your monthly supply, our guide explains exactly how the dosing calendar maps to each pen. A month's treatment is one pen at whichever strength your prescriber has confirmed.
Tirzepatide is a prescription-only medicine. A free consultation with a GPhC-registered prescriber at nume is the right starting point, they assess your health history, confirm whether Mounjaro is clinically suitable, and manage your dose from day one.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.